Dabrafenib,trade name Tafinlar,is a drug for the treatment of cancers associated with a mutated version of the gene BRAF - especially skin cancer. Dabrafenib acts as an inhibitor of the associated enzyme B-Raf,which plays a role in the regulation of cell growth. Dabrafenib has clinical activity with a safety profile in patients with BRAF(V600)-mutated metastatic melanoma | |
Lizenzart: | Lizenzfrei |
Credit: | Science Photo Library / Pasieka, Alfred |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |